Mill Creek Capital Advisors, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1964962
Conshohocken, PA
Position in TMO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,272,378
-$788,538 QoQ
Shares Held
8,692
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Mill Creek Capital Advisors, LLC holds $5,126,718 across 4 Diagnostics & Research names. TMO ranks #1 (83.3% of the industry book) .
All Filings in TMO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,272,378 | 8,692 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,060,916 | 8,734 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,459,273 | 9,194 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,737,124 | 9,217 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,748,099 | 9,542 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,338,718 | 8,340 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,670,431 | 9,167 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $7,363,748 | 13,316 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,728,349 | 13,297 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,914,087 | 16,794 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,933,638 | 9,747 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,144,976 | 9,861 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,278,972 | 9,159 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,049,827 | 9,170 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||